Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study - Raje, N; Terpos, E; Willenbacher, W (Lancet Oncol, 2018)